Company Filings Shed Light on Trump’s Drug Pricing Deals
Pfizer CEO Albert Bourla speaks in the Oval Office on Sept. 30, 2025, as (L-R) Secretary of Health and Human Services Robert F. Kennedy Jr., Administrator for the Centers for Medicare and Medicaid Services Mehmet Oz, and President Donald Trump look on. Win McNamee/Getty Images Sixteen drugmakers have entered into or are negotiating confidential pricing